Targeting the A2B adenosine receptor during gastrointestinal ischemia and inflammation

Expert Opinion on Therapeutic Targets

Volumn 13, Issue 11, 2009, Pages 1267-1277

  Eltzschig, Holger K ^a,b,c   Rivera Nieves, Jesus ^a   Colgan, Sean P ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

A2B; adenosine kinase; adenosine receptor; CD39; CD73; ecto 5 nucleotidase; ecto apyrase; equilibrative nucleoside transporter; inflammation; ischemia

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE; ADENOSINE A2B RECEPTOR; ADENOSINE A2B RECEPTOR AGONIST; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE RECEPTOR STIMULATING AGENT; ADENOSINE TRIPHOSPHATE; BAY 60 6583; CD39 ANTIGEN; GASTROINTESTINAL AGENT; HYPOXIA INDUCIBLE FACTOR 1; UNCLASSIFIED DRUG;

COLITIS; DIGESTIVE SYSTEM INFLAMMATION; EXTRACELLULAR MATRIX; GENE TARGETING; HUMAN; HYDROLYSIS; INTESTINE ISCHEMIA; INTRACELLULAR SIGNALING; MOLECULARLY TARGETED THERAPY; NONHUMAN; NUCLEIC ACID METABOLISM; NUCLEOSIDE TRANSPORT; PROTEIN TARGETING; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; DRUG DELIVERY SYSTEM; DRUG EFFECT; ENTEROPATHY; INFLAMMATION; ISCHEMIA; METABOLISM; PATHOPHYSIOLOGY;

ADENOSINE; ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; INFLAMMATION; INTESTINAL DISEASES; ISCHEMIA; RECEPTOR, ADENOSINE A2B; SIGNAL TRANSDUCTION;

EID: 73449115750     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728220903241666     Document Type: Review

References (99)

1. Carden DL, Granger DN. Pathophysiology of ischaemia-reperfusion injury. J Pathol 2000;190(3):255-66 (Pubitemid 30141372)
2. Mallick IH, Yang W, Winslet MC, Seifalian AM. Ischemia-reperfusion injury of the intestine and protective strategies against injury. Dig Dis Sci 2004;49(9):1359-77 (Pubitemid 39273608)
3. Eltzschig HK, Collard CD. Vascular ischaemia and reperfusion injury. Br Med Bull 2004;70(1):71-86 (Pubitemid 40069373)
4. Turnage RH, Guice KS, Oldham KT. The effects of hypovolemia on multiple organ injury following intestinal reperfusion. Shock 1994;1(6):408-12
5. Taylor CT, Colgan S P. Hypoxia and gastrointestinal disease. J Mol Med 2007;85(12):1295-300 (Pubitemid 50004090)
6. Karhausen J, Furuta GT, Tomaszewski JE, et al. Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J Clin Invest 2004;114(8):1098-106 (Pubitemid 39578699)
7. Karhausen J, Haase VH, Colgan S P. Infammatory hypoxia: role of hypoxia-inducible factor. Cell Cycle 2005;4(2):256-8 (Pubitemid 41365330)
8. Robinson A, Keely S, Karhausen J, et al. Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition. Gastroenterology 2008;134(1):145-55 (Pubitemid 350309309)
9. Louis NA, Robinson AM, MacManus CF, et al. Control of IFN-αA by CD73: implications for mucosal infammation. J Immunol 2008;180(6):4246-55
10. Naganuma M, Wiznerowicz EB, Lappas CM, et al. Cutting edge: critical role for A2A adenosine receptors in the T cell-mediated regulation of colitis. J Immunol 2006;177(5):2765-9 (Pubitemid 44277790)
11. Hart ML, Henn M, Kohler D, et al. Role of extracellular nucleotide phosphohydrolysis in intestinal ischemia-reperfusion injury. FASEB J 200822(8):2784-97
12. Sitkovsky M, Lukashev D. Regulation of immune cells by local-tissue oxygen tension: HIF1α and adenosine receptors. Nat Rev Immunol 2005;5(9):712-21 (Pubitemid 43086172)
13. Sitkovsky MV, Lukashev D, Apasov S, et al. Physiological control of immune response and infammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu Rev Immunol 2004;22(1):657-82 (Pubitemid 38680437)
14. Ohta A, Sitkovsky M. Role of G-protein-coupled adenosine receptors in downregulation of infammation and protection from tissue damage. Nature 2001;414(6866):916-20 (Pubitemid 34024743)
15. Eltzschig HK, Ibla JC, Furuta GT, et al. Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J Exp Med 2003;198(5):783-96 (Pubitemid 37087777)
16. Eltzschig HK, Thompson LF, Karhausen J, et al. Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism. Blood 2004;104(13):3986-92 (Pubitemid 39620148)
17. Thompson L F, Eltzschig HK, Ibla JC, et al. Crucial role for ecto-5′-nucleotidase (CD73) in vascular leakage during hypoxia. J Exp Med 2004;200(11):1395-405 (Pubitemid 39657287)
18. Hart ML, Kohler D, Eckle T, et al. Direct treatment of mouse or human blood with soluble 5′-nucleotidase inhibits platelet aggregation. Arterioscler Thromb Vasc Biol 2008;28(8):1477-83
19. Kohler D, Eckle T, Faigle M, et al. CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury. Circulation 2007;116(16):1784-94 (Pubitemid 350287103)
20. Eckle T, Faigle M, Grenz A, et al. A2B adenosine receptor dampens hypoxia-induced vascular leak. Blood 2008;111(4):2024-35 (Pubitemid 351451513)
21. Morote-Garcia JC, Rosenberger P, Kuhlicke J, Eltzschig HK. HIF-1-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak. Blood 2008;111(12):5571-80
22. Eckle T, Krahn T, Grenz A, et al. Cardioprotection by ecto-5′-nucleotidase (CD73) and A2B adenosine receptors. Circulation 2007;115(12):1581-90 (Pubitemid 46648643)
23. Eckle T, Kohler D, Lehmann R, et al. Hypoxia inducible factor (HIF)-1 Is central to cardioprotection: a new paradigm for ischemic preconditioning. Circulation 2008;118(2):166-75
24. Khoury J, Ibla JC, Neish AS, Colgan S P. Antiinfammatory adaptation to hypoxia through adenosine-mediated cullin-1 deneddylation. J Clin Invest 2007;117(3):703-11 (Pubitemid 46348528)
25. Eckle T, Fullbier L, Wehrmann M, et al. Identifcation of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury. J Immunol 2007;178(12):8127-37 (Pubitemid 46898085)
26. Frick JS, MacManus C F, Scully M, et al. Contribution of adenosine A2B receptors to infammatory parameters of experimental colitis. J Immunol 2009;182(8):4957-64
27. Hart ML, Much C, Gorzolla IC, et al. Extracellular adenosine production by ecto-5′-nucleotidase protects during murine hepatic ischemic preconditioning. Gastroenterology 2008;135(5):1739-50 e3
28. Hart ML, Henn M, Kohler D, et al. Role of extracellular nucleotide phosphohydrolysis in intestinal ischemia-reperfusion injury. FASEB J 2008;22(8):2784-97
29. Hart ML, Jacobi B, Schittenhelm J, et al. Cutting Edge: A2B Adenosine receptor signaling provides potent protection during intestinal ischemia/reperfusion injury. J Immunol 2009;182(7):3965-8
30. Kong T, Westerman KA, Faigle M, et al. HIF-dependent induction of adenosine A2B receptor in hypoxia. Faseb J 2006;20(13):2242-50 (Pubitemid 44953854)
31. Grenz A, Osswald H, Eckle T, et al. The reno-vascular A2B adenosine receptor protects the kidney from ischemia. PLoS Med 2008;5(6):e137. Published online 24 June 2008, doi:10.1371/journal.pmed.0050137 (Pubitemid 351919118)
32. Eckle T, Grenz A, Laucher S, Eltzschig HK. A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fuid clearance in mice. J Clin Invest 2008;118(10):3301-15
33. Kolachala VL, Bajaj R, Chalasani M, Sitaraman SV. Purinergic receptors in gastrointestinal infammation. Am J Physiol Gastrointest Liver Physiol 2008;294(2):G401-10
34. Antonioli L, Fornai M, Colucci R, et al. Pharmacological modulation of adenosine system: novel options for treatment of infammatory bowel diseases. Infamm Bowel Dis 2008;14(4):566-74 (Pubitemid 351571838)
35. Antonioli L, Fornai M, Colucci R, et al. Regulation of enteric functions by adenosine: pathophysiological and pharmacological implications. Pharmacol Ther 2008;120(3):233-53
36. Eltzschig HK, Eckle T, Mager A, et al. ATP release from activated neutrophils occurs via connexin 43 and modulates adenosine-dependent endothelial cell function. Circ Res 2006;99(10):1100-8 (Pubitemid 44729934)
37. Faigle M, Seessle J, Zug S, et al. ATP release from vascular endothelia occurs across Cx43 hemichannels and is attenuated during hypoxia. PLoS ONE 2008;3(7):e2801. Published online 30 July 2008, doi:10.1371/journal.pone.0002801
38. Weissmuller T, Campbell EL, Rosenberger P, et al. PMNs facilitate translocation of platelets across human and mouse epithelium and together alter fuid homeostasis via epithelial cell-expressed ecto-NTPDases. J Clin Invest 2008;118(11):3682-92
39. Chen Y, Corriden R, Inoue Y, et al. ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science 2006;314(5806):1792-5 (Pubitemid 44969094)
40. Zimmermann H. Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch Pharmacol 2000;362(4-5):299-309
41. Robson SC, Wu Y, Sun X, et al. Ectonucleotidases of CD39 family modulate vascular infammation and thrombosis in transplantation. Semin Thromb Hemost 2005;31(2):217-33 (Pubitemid 40605196)
42. Guckelberger O, Sun XF, Sevigny J, et al. Benefcial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury. Thromb Haemost 2004;91(3):576-86 (Pubitemid 38396881)
43. Strohmeier GR, Lencer WI, Patapoff TW, et al. Surface expression, polarization, and functional signifcance of CD73 in human intestinal epithelia. J Clin Invest 1997;99(11):2588-601 (Pubitemid 27259805)
44. Fredholm BB. Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ 2007;14(7):1315-23 (Pubitemid 46965261)
45. Linden J. Adenosine in tissue protection and tissue regeneration. Mol Pharmacol 2005;67(5):1385-7 (Pubitemid 40594134)
46. Hasko G, Csoka B, Nemeth ZH, et al. A2B adenosine receptors in immunity and infammation. Trends Immunol 2009;30(6):263-70
47. Hasko G, Linden J, Cronstein B, Pacher P. Adenosine receptors: therapeutic aspects for infammatory and immune diseases. Nat Rev Drug Discov 2008;7(9):759-70
48. Day YJ, Huang L, Mcduffe MJ, et al. Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow-derived cells. J Clin Invest 2003;112(6):883-91 (Pubitemid 38063746)
49. Deaglio S, Dwyer KM, Gao W, et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 2007;204(6):1257-65 (Pubitemid 46919862)
50. Lappas CM, Day YJ, Marshall MA, et al. Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation. J Exp Med 2006;203(12):2639-48 (Pubitemid 44833340)
51. Rosenberger P, Schwab JM, Mirakaj V, et al. Hypoxia-inducible factor-dependent induction of netrin-1 dampens infammation caused by hypoxia. Nat Immunol 2009;10(2):195-202
52. Eckle T, Kohler D, Lehmann R, et al. Hypoxia-inducible factor-1 is central to cardioprotection: a new paradigm for ischemic preconditioning. Circulation 2008;118(2):166-75
53. Loffer M, Morote-Garcia JC, Eltzschig SA, et al. Physiological roles of vascular nucleoside transporters. Arterioscler Thromb Vasc Biol 2007;27(5):1004-13 (Pubitemid 46641985)
54. Morote-Garcia JC, Rosenberger P, Kuhlicke J, Eltzschig HK. HIF-1-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak. Blood 2008;111(12):5571-80
55. Eltzschig HK, Faigle M, Knapp S, et al. Endothelial catabolism of extracellular adenosine during hypoxia: the role of surface adenosine deaminase and CD26. Blood 2006;108(5):1602-10 (Pubitemid 44316128)
56. Grenz A, Zhang H, Eckle T, et al. Protective role of ecto-5′- nucleotidase (CD73) in renal ischemia. J Am Soc Nephrol 2007;18(3):833-45 (Pubitemid 46434500)
57. Grenz A, Zhang H, Hermes M, et al. Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury. FASEB J 2007;21(11):2863-73 (Pubitemid 47372753)
58. Taylor CT. Interdependent roles for hypoxia inducible factor and nuclear factor-κB in hypoxic infammation. J Physiol 2008;586(Pt 17):4055-9
59. Synnestvedt K, Furuta G T, Comerford KM, et al. Ecto-5′- nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J Clin Invest 2002;110(7):993-1002
60. Eltzschig HK, Kohler D, Eckle T, et al. Central role of Sp1-regulated CD39 in hypoxia/ischemia protection. Blood 2009;113(1):224-32
61. Reutershan J, Vollmer I, Stark S, et al. Adenosine and infammation: CD39 and CD73 are critical mediators in LPS-induced PMN traffcking into the lungs. FASEB J 2009;23(2):473-82
62. Zhou Y, Mohsenin A, Morschl E, et al. Enhanced airway infammation and remodeling in adenosine deaminase-defcient mice lacking the A2B adenosine receptor. J Immunol 2009;182(12):8037-46
63. Casanello P, Torres A, Sanhueza F, et al. Equilibrative nucleoside transporter 1 expression is downregulated by hypoxia in human umbilical vein endothelium. Circ Res 2005;97(1):16-24 (Pubitemid 40982318)
64. Chaudary N, Naydenova Z, Shuralyova I, Coe IR. Hypoxia regulates the adenosine transporter, mENT1, in the murine cardiomyocyte cell line, HL-1. Cardiovasc Res 2004;61(4):780-8 (Pubitemid 38249477)
65. Eltzschig HK, Abdulla P, Hoffman E, et al. HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia. J Exp Med 2005;202(11):1493-505 (Pubitemid 41746596)
66. Morote-Garcia JC, Rosenberger P, Nivillac NM, et al Hypoxia-inducible factor-dependent repression of equilibrative nucleoside transporter 2 attenuates mucosal infammation during intestinal hypoxia. Gastroenterology 2009;136(2):607-18
67. Sitkovsky MV. Damage control by hypoxia-inhibited AK. Blood 2008;111(12):5424-5
68. Antonioli L, Fornai M, Colucci R, et al. Inhibition of adenosine deaminase attenuates infammation in experimental colitis. J Pharmacol Exp Ther 2007;322(2):435-42 (Pubitemid 47105786)
69. Guzman J, Yu JG, Suntres Z, et al. ADOA3R as a therapeutic target in experimental colitis: proof by validated high-density oligonucleotide microarray analysis. Infamm Bowel Dis 2006;12(8):766-89 (Pubitemid 44253762)
70. Mabley J, Soriano F, Pacher P, et al. The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5′N-methyluronamide, is protective in two murine models of colitis. Eur J Pharmacol 2003;466(3):323-9 (Pubitemid 36412095)
71. Odashima M, Bamias G, Rivera-Nieves J, et al. Activation of A2A adenosine receptor attenuates intestinal infammation in animal models of infammatory bowel disease. Gastroenterology 2005;129(1):26-33 (Pubitemid 41002039)
72. Yang D, Koupenova M, McCrann DJ, et al. The A2b adenosine receptor protects against vascular injury. Proc Natl Acad Sci USA 2008;105(2):792-6 (Pubitemid 351171787)
73. Yang D, Zhang Y, Nguyen HG, et al. The A2B adenosine receptor protects against infammation and excessive vascular adhesion. J Clin Invest 2006;116(7):1913-23
74. Hasegawa T, Bouis D, Liao H, et al. Ecto-5′ nucleotidase (CD73)-mediated adenosine generation and signaling in murine cardiac allograft vasculopathy. Circ Res 2008;103(12):1410-21
75. Kolachala V, Ruble B, Vijay-Kumar M, et al. Blockade of adenosine A2B receptors ameliorates murine colitis. Br J Pharmacol 2008;155(1):127-37
76. Kolachala VL, Vijay-Kumar M, Dalmasso G, et al. A2B adenosine receptor gene deletion attenuates murine colitis. Gastroenterology 2008;135(3):861-70
77. Kruschewski M, Foitzik T, Perez-Canto A, et al. Changes of colonic mucosal microcirculation and histology in two colitis models: an experimental study using intravital microscopy and a new histological scoring system. Dig Dis Sci 2001;46:2336-43 (Pubitemid 33042330)
78. Hauser CJ, Locke RR, Kao HW, et al. Visceral surface oxygen tension in experimental colitis in the rabbit. J Lab Clin Med 1988;112:68-71
79. Hatoum OA, Binion DG, Otterson M F, Gutterman DD. Acquired microvascular dysfunction in infammatory bowel disease: loss of nitric oxide-mediated vasodilation. Gastroenterology 2003;125(1):58-69 (Pubitemid 36799107)
80. Yokoyama K, Mitomi H, Kobayashi K, et al. Obliterative arteritis with nitric oxide synthase and HLA-DR expression in Crohn's colitis. Hepatogastroenterology 2001;48:401-7 (Pubitemid 32391576)
81. Evans SM, Hahn S, Pook DR, et al. Detection of hypoxia in human squamous cell carcinoma by EF5 binding. Cancer Res 2000;60:2018-24 (Pubitemid 30207665)
82. Schofeld CJ, Ratcliffe PJ. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 2004;5(5):343-54 (Pubitemid 38579472)
83. Fraisl P, Aragones J, Carmeliet P. Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and infammatory disease. Nat Rev Drug Discov 2009;8(2):139-52
84. Kaelin WG Jr, Ratcliffe PJ. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell 2008;30(4):393-402 (Pubitemid 351681994)
85. Ratcliffe PJ. HIF-1 and HIF-2: working alone or together in hypoxia? J Clin Invest 2007;117(4):862-5 (Pubitemid 46556739)
86. Semenza GL. Life with oxygen. Science 2007;318(5847):62-4 (Pubitemid 47538005)
87. Wang G, Jiang B, Rue E, Semenza G. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. PNAS 1995;92(12):5510-4
88. Wenger RH. Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J 2002;16(10):1151-62 (Pubitemid 34815403)
89. Weissmuller T, Campbell EL, Rosenberger P, et al. PMNs facilitate translocation of platelets across human and mouse epithelium and together alter fuid homeostasis via epithelial cell-expressed ecto-NTPDases. J Clin Invest 2008;118(11):3682-92
90. Cramer T, Yamanishi Y, Clausen BE, et al. HIF-1α is essential for myeloid cell-mediated infammation. Cell 2003;112(5):645-57 (Pubitemid 36331777)
91. Peyssonnaux C, Datta V, Cramer T, et al. HIF-1α expression regulates the bactericidal capacity of phagocytes. J Clin Invest 2005;115(7):1806-15 (Pubitemid 40979719)
92. Haeberle HA, Durrstein C, Rosenberger P, et al. Oxygen-independent stabilization of hypoxia inducible factor (HIF)-1 during RSV infection. PLoS ONE 2008;3(10):3352. Published online 7 October 2008, doi:10.1371/journal.pone. 0003352
93. Cummins E P, Seeballuck F, Keely SJ, et al. The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis. Gastroenterology 2008;134(1):156-65
94. Kempf VA, Lebiedziejewski M, Alitalo K, et al. Activation of hypoxia-inducible factor-1 in bacillary angiomatosis: evidence for a role of hypoxia-inducible factor-1 in bacterial infections. Circulation 2005;111(8):1054-62
95. Kuhn R, Lohler J, Rennick D, et al. Interleukin-10-defcient mice develop chronic enterocolitis. Cell 1993;75(2):263-74 (Pubitemid 23320290)
96. Collins CB, Ho J, Wilson TE, et al. CD44 defciency attenuates chronic murine ileitis. Gastroenterology 2008;135(6):1993-2002
97. Reuter BK, Pizarro T T. Mechanisms of tight junction dysregulation in the SAMP1/YitFc model of Crohn's disease-like ileitis. Ann NY Acad Sci 2009;1165:301-7
98. Bachmann C, Klibanov AL, Olson TS, et al. Targeting mucosal addressin cellular adhesion molecule (MAdCAM)-1 to noninvasively image experimental Crohn's disease. Gastroenterology 2006;130(1):8-16 (Pubitemid 43049830)
99. Rivera-Nieves J, Bamias G, Vidrich A, et al. Emergence of perianal fstulizing disease in the SAMP1/YitFc mouse, a spontaneous model of chronic ileitis. Gastroenterology 2003;124(4):972-82 (Pubitemid 36389800)